MEDS trxadehealth.com: צמיחת רווחי EPS רבעונית

Stable demand for medications ensures the resilience of the TRxADE HEALTH (MEDS) IT platform. The quarterly EPS growth rate visualizes this trend, where the -34.70 level serves as a critical benchmark. Business efficiency is based on the scale of the B2B marketplace and the number of pharmacy partners. However, a liquidity shortage and the use of reserves to support services are creating financial pressure on the company.
TRxADE HEALTH, Inc. (MEDS) - פילוחי מדדים ודוחות פיננסיים

This indicator measures the rate of change in earnings per share, converting quarterly reports into a daily format to identify long-term profitability trends. By analyzing the relative quarterly EPS dynamics with a current value of -34.70, an investor can assess the resilience of TRxADE HEALTH, Inc. (MEDS) against pressure from online behemoths and the risks of severed ties with pharmacy partners.